Showing results (91-100 of 325) with videos related to

Sort By:
Pageof 33
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HITJ M Walenga, W P Jeske, D E Wallis, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass modelJ M Walenga, M Bakhos, H L Messmore, et al.
Journal of Medicinal Chemistry|June 1, 1990
Oligosaccharide mapping of low molecular weight heparins: structure and activity differencesR J Linhardt, D Loganathan, A al-Hakim, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopeniaK F Izban, H W Lietz, D A Hoppensteadt, et al.
American Journal of Clinical Pathology|October 1, 1990
Global and molecular hemostatic markers in acute myeloid leukemiaV B Reddy, A Kowal-Vern, D A Hoppensteadt, et al.
Pageof 33